Ovatech Plans Pivotal Trial For Non-Hormonal Contraceptive Ring
This article was originally published in The Gray Sheet
Executive Summary
Ovatech aims to begin a pivotal trial in April for its Ovaprene non-hormonal intravaginal silicone ring barrier contraceptive, pending FDA clearance of an investigational device exemption, the company said.
You may also be interested in...
People In Brief
Vascular Nanotransfer Technologies and Pinnacle Medical Solutions appoint new CEOs. EarlySense names president. More people news.
Contraceptive Devices Must Be Fully Covered By Private Plans, HHS Says
Starting Aug. 1, 2012, FDA-approved birth control devices must be fully covered by all new private health insurance plans and by Medicare, HHS Secretary Kathleen Sebelius said Aug. 1.
Contraceptive Devices Must Be Fully Covered By Private Plans, HHS Says
Starting Aug. 1, 2012, FDA-approved birth control devices must be fully covered by all new private health insurance plans and by Medicare, HHS Secretary Kathleen Sebelius said Aug. 1.